Actoplus Met XR and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Actoplus Met XR and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: metformin / pioglitazone
Brand name: Actoplus Met, Actoplus Met XR
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Actoplus Met XR-Insulin glargine, recombinant Subcutaneous
- Actoplus Met XR-Insulin glulisine
- Actoplus Met XR-Insulin Glulisine (Cartridges and Pens)
- Actoplus Met XR-Insulin Glulisine (Vials)
- Actoplus Met XR-Insulin glulisine Subcutaneous
- Actoplus Met XR-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Actos
- Insulin glargine and lixisenatide Subcutaneous-Acuflex
- Insulin glargine and lixisenatide Subcutaneous-Acular
- Insulin glargine and lixisenatide Subcutaneous-Acular eent
- Insulin glargine and lixisenatide Subcutaneous-Acular LS
- Insulin glargine and lixisenatide Subcutaneous-Acular PF